Unlike traditional calorie-restriction diets that rely on willpower, GLP-1 therapy reduces the appetite drive itselfmaking smaller portions feel satisfying
Accessed 26 Feb 2024 Pazzagli L, Andersen M, Sessa M (2022) Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: a simulation study
Attend expert-led Workshops (in person or virtual) and connect with others on similar journeys
Class Action Lawsuit Filed Against GLP-1 Drug Manufacturers Novo Nordisk and Eli Lilly and Company In addition to multidistrict litigation, plaintiffs have also sought class action lawsuits against Novo Nordisk and Eli Lilly, the companies that manufacture and market semaglutide drugs, including Ozempic and Wegovy
Gastrointestinal Hormones and Neurotransmitters
These receptors in other areas of the body make it promising to use GLP-1s and similar drugs to treat other conditions, says Isaacs